Brief: Exopharm Ltd Says Loss For Year Attributable A$7.1 Mln
Aug 29 (Reuters) - Exopharm Ltd EX1.AX :
* LOSS FOR YEAR ATTRIBUTABLE A$7.1 MILLION
* FY REVENUES AND OTHER INCOME FROM ORDINARY ACTIVITIES DOWN
19.0%
TO A$3.4 MILLION
Source text for Eikon: ID:nASXbWgPfZ
Further company coverage: EX1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entropy Neurodynamics
See all newsBrief: Entropy Neurodynamics Seeks Trading Halt
Brief: Entropy Neurodynamics Says Strategic Agreement Signed With CDMO Biocina
Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
Brief: Entropy Neurodynamics Requests Trading Halt
Brief: Entropy Neurodynamics Seeks Trading Halt